BiotechTube
Home/Pliant Therapeutics/Éric Lefebvre, M.D.
ÉL

Éric Lefebvre, M.D.

Chief Executive Officer

Pliant Therapeutics

Roles

Chief Executive OfficeratPliant Therapeutics
Chief Medical OfficeratPliant Therapeutics

Therapeutic Areas

Fibrotic DiseasesPulmonaryHepatologyOncology

Pliant Therapeutics Pipeline

DrugIndicationPhase
Bexotegrast (PLN-74809)Idiopathic Pulmonary Fibrosis (IPF)Phase 2b
PLN-101095Advanced Solid TumorsPhase 1
PLN-101325Undisclosed Fibrotic IndicationPreclinical
Muscular Dystrophy ProgramMuscular DystrophyDiscovery

Leadership Team at Pliant Therapeutics

KC
Keith Cummings, M.D.
Chief Financial Officer
BC
Bernard Coulie, M.D., Ph.D.
President and Chief Executive Officer
HH
Hans Hull, M.Sc.
Chief Commercial Officer
JP
John P. McLaughlin
Chief Business Officer
X(
Xiaokui (Kevin) Zhang, Ph.D.
Chief Scientific Officer
LC
Lily Cheung, Ph.D.
Senior Vice President, Regulatory Affairs & Quality Assurance
RJ
Robert J. Benschop, Ph.D.
Senior Vice President, Research & Non-Clinical Development
JG
John G. M. Lee, J.D.
Senior Vice President, General Counsel & Corporate Secretary
GG
Gary G. Gysin
Board Member
BE
Bryan E. Roberts, Ph.D.
Board Member
View full Pliant Therapeutics profile